
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Kerry Group Plc (PK) | USOTC:KRYAY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.52 | 1.47% | 105.184 | 103.13 | 106.28 | 106.1844 | 104.53 | 104.53 | 6,038 | 22:00:00 |
By Kyle Morris
Kerry Group PLC said Tuesday that it has reached agreement to acquire around 92% of c-LEcta GmbH for 137 million euros ($154.9 million), and that it acquired Enmex SA de CV on Dec. 14 for EUR62 million.
The Ireland-based food company said the deal for c-LEcta, a biotechnology innovation company, is strategically important and will accelerate Kerry's innovation capabilities in enzyme engineering, fermentation and bio-process development.
Enmex is a enzyme manufacturer based in Mexico, supplying multiple bio-process solutions for food, beverage and animal-nutrition markets, Kerry said. Enmex's enzyme portfolio and manufacturing infrastructure will extend Kerry's fermentation and enzyme manufacturing capabilities into Latin America, it said.
Write to Kyle Morris at kyle.morris@dowjones.com
(END) Dow Jones Newswires
February 15, 2022 02:57 ET (07:57 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Kerry (PK) Chart |
1 Month Kerry (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions